MYC and lymphoma: However, it should be noted that the ability of oncogenes like MYC to control the recruitment and function of immune cells in tumors can be counteracted by other genetic aberrations as has been seen using the Eμ-MYC lymphoma model (149, 154), that highlights the complexity of defining the roles of oncogenic alterations in modulating immune cell landscapes both within and between complex molecular lymphoma subtypes.